Day One Biopharmaceuticals
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Day One Biopharmaceuticals's balance sheet done over the years? Its assets were worth $376,048,000 last year, which is more than in the previous period. 8% of Day One Biopharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $29,508,000, which means an increase by 73% compared compared to last year.

Debt to Assets

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN): Debt to assets
2019 27339000 32.52M 118.97%
2020 45661000 94.16M 206.22%
2021 289821000 8.67M 2.99%
2022 349062000 17.02M 4.88%
2023 376048000 29.50M 7.85%

DAWN Balance Sheet (2019 – 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
230.78M85.26M284.30M43.72M27.33M
Short term investments
135.56M257.00M000
Net receivables
00000
Inventory
00000
Other current assets
8.92M1.00M1.01M1.34M7K
Total current assets
375.27M347.87M289.36M45.07M27.33M
Non-current assets:
Property, Plant and Equipment
560K719K284K483K0
Goodwill
00000
Intangible assets
00000
Long term investments
00000
Other non-current assets
214K469K169K107K0
Total non-current assets
774K1.18M453K590K0
Total assets
376.04M349.06M289.82M45.66M27.33M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
006.60M1.56M0
Short term debt
816K405K204K198K0
Total current liabilities
29.50M16.61M8.65M1.99M2.02M
Non-current liabilities:
Long term debt
0408K16K204K0
Deferred tax
00000
Other non-current liabilities
00091.96M0
Total non-current liabilities
0408K16K92.16M30.50M
Total liabilities
29.50M17.02M8.67M94.16M32.52M
Data sourceData sourceData source